The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)

Market Cap	9.05B
Revenue (ttm)	11.23B
Net Income (ttm)	592.31M
Shares Out	31.24M
EPS (ttm)	18.96
PE Ratio	15.28
Forward PE	n/a
Dividend	6.30 (2.18%)
Ex-Dividend Date	Oct 28, 2024

Volume	29,701
Open	291.00
Previous Close	289.20
Day's Range	286.30 - 292.00
52-Week Range	223.50 - 384.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 27, 2025

About DSE: IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2024, IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.